The experience of using the atypical antipsychotic sertindole in psychiatric inpatient clinics in Russia

Ivanets N.N.; Kinkul'kina M.A.; Avdeeva T.I.

doi:https://doi.org/

Ivanets N.N.

Kafedra psikhiatrii i meditsinskoĭ psikhologii Moskovskoĭ meditsinskoĭ akademii im. I.M. Sechenova

Kinkul'kina M.A.

Kafedra psikhiatrii i meditsinskoĭ psikhologii Moskovskoĭ meditsinskoĭ akademii im. I.M. Sechenova

Avdeeva T.I.

The experience of using the atypical antipsychotic sertindole in psychiatric inpatient clinics in Russia

Authors:

Ivanets N.N., Kinkul'kina M.A., Avdeeva T.I.

More about the authors

Journal: S.S. Korsakov Journal of Neurology and Psychiatry. 2011;111(6): 37‑41

Read: 2671 times

Download PDF (RU)

Contact the author

Table of contents

To cite this article:

Ivanets NN, Ivanets NN, Ivanets NN, et al. . The experience of using the atypical antipsychotic sertindole in psychiatric inpatient clinics in Russia. S.S. Korsakov Journal of Neurology and Psychiatry. 2011;111(6):37‑41. (In Russ.)

Подписка 2026 Журнал неврологии и психиатрии им. С.С. Корсакова (S.S. Korsakov Journal of Neurology and Psychiatry)

Использование инфографики авторами научных работ

Close metadata

Abstract:

One hundred and fifty psychiatrists from 61 clinics of 30 cities located in 8 regions of the Russian Federation took part in the study. The study included 896 patients treated with sertindole. The duration of illness was from 1 month to 50 years (mean 9,55±8,21), a number of previous relapses varied from 0 to 20 and more (mean 5,79± 6,68). Each patient was followed up for 6 weeks. Patient's state was assessed clinically and with the CGI. The statistically significant improvement was seen from the first week of treatment and the percentage of patients with marked mental disorders was constantly decreased from the first to the 6th week. It has been concluded that sertindole is an effective drug for stopping psychotic symptoms in the real practice of treatment of schizophrenic patients. It is well-tolerated and allows to reduce a number of concurrent drugs used for treatment.

Keywords:

schizophrenia

antipsychotic treatment

sertindole

antipsychotic treatment

sertindole

Authors:

Ivanets N.N.

Kafedra psikhiatrii i meditsinskoĭ psikhologii Moskovskoĭ meditsinskoĭ akademii im. I.M. Sechenova

Kinkul'kina M.A.

Kafedra psikhiatrii i meditsinskoĭ psikhologii Moskovskoĭ meditsinskoĭ akademii im. I.M. Sechenova

Avdeeva T.I.

Close metadata

References:

Avedisova A.S., Chakhava K.O., Yastrebova V.V.Effektivnost' i perenosimost' preparata serdolekt (sertindol) pri nevrozopodobnoi shizofrenii s preobladaniem v klinicheskoi kartine zabolevaniya simptomov astenii. Sotsial'naya i klinicheskaya psikhiatriya 2010; 2: 39-44.
Onegina E.Yu., Arsen'eva T.B., Shvedova A.K.Opyt primeneniya sertindola v usloviyakh statsionara. Psikhiatriya i psikhofarmakoterapiya 2008; 10: 3: 45-47.
Pogodina M.G., Shknevskii M.A.Opyt primeneniya atipichnogo antipsikhotika serdolekta (sertindol) v psikhiatricheskoi praktike: opisanie klinicheskikh sluchaev. Psikhiatriya i psikhofarmakoterapiya 2008; 10: 1: 33-37.
Azorin J.-M., Murteira S., Hansen K. et al.Evaluation of patients on sertindole treatment after failure of other antipsychotics: a retrospective analysis. BMC Psychiat 2008; 8: 16.
Fleischhacker W.W.New drugs for the treatment of schizophrenic patients. Acta Psychiat Scand 1995; 91: Suppl 388: 24-30.
Hale A.S.A review of the safety and tolerability of sertindole. Int Clin Psychopharmacol 1998; 13: Suppl 3: 65-70.
Hale A., Azorin J.-M., Kasper S. et al.Sertindole improves both the positive and negative symptoms of schizophrenia: results of a phase III trial. Int J Psychiat Clin Pract 2000; 4: 55-62.
Murdoch D., Keating G.M.Sertindole. A review of its use in schizophrenia. CNS Drugs 2006; 20: 3: 233-255.
Perquin L., Steinert T.Review of the efficacy, tolerability and safety of sertindole in clinical trials. CNS Drugs 2004; 18: Suppl 2: 19-30.